1-8 of 8
Stacey Tannheimer, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The BET Inhibitor GS-626510 Converges with Idelalisib through the Inhibition of Tumor-Macrophage Crosstalk and Cytokine Production in Diffuse Large B-Cell Lymphoma

Juan G Valero, PhD, Aranzazu Chamorro-Jorganes, PhD, Katie Walker, PhD, Martina Guerrero-Hernandez, MSc, Vanina Rodriguez, Clara Recasens-Zorzo, MSc, Anna Esteve-Arenys, MSc, Eriong Lee-Verges, MSc, Alba Matas-Cespedes, PhD, Neus Serrat, PhD, Dolors Colomer, PhD, Armando Lopez-Guillermo, Stacey Tannheimer, PhD, Patricia Pérez-Galán, PhD, Gael Roue, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4108.
https://doi.org/10.1182/blood.V130.Suppl_1.4108.4108
Published: 2017
Journal Articles

Enhanced Efficacy of the SYK Inhibitor Entospletinib and Chemotherapy in Infant Acute Lymphoblastic Leukemia

Joseph Patrick Loftus, BS, Anella Yahiaoui, BS, Feng Shen, MDPhD, David Lopez, Igor Mikaelian, DVM, Patrick A Brown, MD, Stacey Tannheimer, PhD, Ann Forslund, PhD, Sarah K Tasian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2611.
https://doi.org/10.1182/blood.V130.Suppl_1.2611.2611
Published: 2017
Journal Articles

Idelalisib Interferes with the Crosstalk of Follicular Lymphoma and Its Immune Microenvironment and Potentiates the Activity of ABT-199

Martina Guerrero-Hernandez, MSc, Alba Matas-Cespedes, PhD, Neus Serrat, PhD, Anella Yahiaoui, BS, Juan G Valero, PhD, Laura Magnano, MD, Alfredo Rivas-Delgado, MD, Dolors Colomer, PhD, Elias Campo, MD PhD, Armando Lopez-Guillermo, Gael Roue, PhD, Stacey Tannheimer, PhD, Patricia Pérez-Galán, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2813.
https://doi.org/10.1182/blood.V130.Suppl_1.2813.2813
Published: 2017
Journal Articles

Acute Lymphoblastic Leukemia Cells Bypass the Blood Brain Barrier to Enter the CNS Via a Neuronal Developmental Pathway

Hisayuki Yao, MD PhD, Matthew Warner, PhD, Trevor Price, PhD, Lindsey Olivere, Gaia Cantelli, PhD, Sarah Ridge, PhD, Brandon Ngo, Surya Ravichandran, Stacey Tannheimer, PhD, Anjen Chenn, MD PhD, Dorothy A. Sipkins, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 144.
https://doi.org/10.1182/blood.V130.Suppl_1.144.144
Published: 2017
Journal Articles

Investigation of the Mechanism of Idelalisib Resistance in the Follicular Lymphoma WSU-Fsccl Cell Line

Rick Sorensen, BS, Sarah Meadows, Anella Yahiaoui, BS, Li Li, PhD, Peng Yue, PhD, Adam Kashishian, BS, Christophe Queva, PhD, Stacey Tannheimer, PhD
Journal: Blood
Blood (2015) 126 (23): 2482.
https://doi.org/10.1182/blood.V126.23.2482.2482
Published: 2015
Journal Articles

Up-Regulation of the PI3K Signaling Pathway Mediates Resistance to Idelalisib

Sarah Meadows, Sorensen Rick, Yahiaoui Anella, Jia Liu, PhD, Li Li, PhD, Peng Yue, PhD, Christophe Queva, PhD, Stacey Tannheimer, PhD
Journal: Blood
Blood (2015) 126 (23): 3707.
https://doi.org/10.1182/blood.V126.23.3707.3707
Published: 2015
Journal Articles

Combination of Idelalisib and ONO/GS-4059 in Lymphoma Cell Lines Sensitive and Resistant to BTK Inhibitors

Stacey Tannheimer, PhD, Jia Liu, PhD, Rick Sorensen, BS, Anella Yahiaoui, BS, Sarah Meadows, Li Li, PhD, Peng Yue, PhD, Kathleen S Keegan, PhD, Jamie Bates, PhD, Daniel Tumas, PhD DVM, Christophe Queva, PhD
Journal: Blood
Blood (2015) 126 (23): 3697.
https://doi.org/10.1182/blood.V126.23.3697.3697
Published: 2015
Journal Articles

The PI3K Delta Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function and B Cell Depletion Mediated By Obinutuzumab (GA101) and Rituximab

Sylvia Herter, PhD, Adam Palazzo, Marina Bacac, PhD, Laura Grosmaire, MS, Christian Frey, PhD, Stefan Pflanz, PhD, Jia Liu, PhD, Stacey Tannheimer, PhD, Pablo Umana, PhD, Christian Klein, PhD, Christophe Queva, PhD
Journal: Blood
Blood (2014) 124 (21): 3342.
https://doi.org/10.1182/blood.V124.21.3342.3342
Published: 2014